| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Seres Therapeutics, Inc. (MCRB) have been net sellers, shedding 490 shares worth roughly $2K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 12.5K | $24.5K | - | |
| Other | 8.7K | $17.0K | - | |
| Other | 8.6K | $16.8K | - | |
| Other | 8.1K | $15.9K | - | |
| Other | 8.0K | $15.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2016 | Eric D. Shaff69 | CFO and EVP | Sale+OE | 6,568 | $28.85 | $189,486.80 | - | |
| Apr 4, 2016 | Roger Pomerantz | President and CEO | Sale+OE | 135,788 | $27.20 | $3,693,795.49 | -85.7% | |
| Apr 4, 2016 | David N Cook | Chief Scientific Officer & EVP | Sell | 61,000 | $26.16 | $1,595,586.00 | -26.6% | |
| Mar 31, 2016 | Eric D. Shaff69 | CFO and EVP | Sale+OE | 7,663 | $26.30 | $201,569.35 | - | |
| Mar 28, 2016 | John G. Aunins | Chief Technology Officer & EVP | Sell | 9,390 | $23.89 | $224,327.10 | -11.2% | |
| Mar 28, 2016 | Eric D. Shaff69 | CFO and EVP | Sale+OE | 5,473 | $24.07 | $131,735.11 | - |